Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 study at the Cleveland Clinic evaluated combining external beam radiotherapy with Zevalin (ibritumomab tiuxetan) for indolent B-ce…
-
FDA approval · 2010-12-16FDA Approved: ZEVALIN — Supplemental Application (Acrotech Biopharma Inc)
The FDA approved a supplemental application for ZEVALIN (ibritumomab tiuxetan) filed by Acrotech Biopharma Inc.
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial update describes the combination of vorinostat and lenalidomide in patients with relapsed or refractory Hodgkin lym…
-
CLINICAL_TRIALS research · 2010-12-02Clinical Trial Update: BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) [Phase 2]
Phase 2 clinical trial evaluating BuEAM conditioning before autologous stem cell transplantation for diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients [Phase 2]
Phase 2 trial of plerixafor (AMD3100) in patients with Non-Hodgkin lymphoma and multiple myeloma has completed with results posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF [Phase 2]
This Phase 2 trial evaluates using plerixafor (AMD3100) with G-CSF to enhance mobilization of peripheral blood stem cells in patients with m…
-
CLINICAL_TRIALS trial_result · 2010-11-24Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients [Phase 2]
A Phase 2 trial evaluated stem cell mobilization using AMD3100 (plerixafor) plus G-CSF in patients with non-Hodgkin lymphoma and multiple my…
-
CLINICAL_TRIALS trial_result · 2010-11-17Clinical Trial Update: Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update on a vaccine therapy given after chemotherapy and peripheral stem cell transplantation for non-Hodgkin's lymphoma has b…
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Host Dendritic Cells in Allograft Patients [Phase 1]
Phase 1 clinical trial update from Icahn School of Medicine at Mount Sinai evaluating host dendritic cells in allograft patients for relapse…
-
CLINICAL_TRIALS trial_result · 2010-10-11Clinical Trial Update: Allo BMT in Advanced Leukemia or High Grade Lymphoma [NA]
Stanford University reports completion of a clinical trial evaluating allogeneic bone marrow transplant in patients with advanced leukemia o…
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer [Phase 4]
Phase 4 clinical trial comparing primary prophylaxis with Neulasta (pegfilgrastim) to secondary prophylaxis after chemotherapy in elderly ca…
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Assess the Oral Bioavailability of New ABT-263 Formulations [Phase 1]
Phase 1 pharmacokinetic study assessing oral bioavailability of new ABT-263 formulations.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial evaluated combination chemotherapy with bone marrow and/or peripheral stem cell transplantation in patients with Non-Hodg…
-
CLINICAL_TRIALS research · 2010-10-01Clinical Trial Update: Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This clinical trial evaluated chemotherapy and radiation therapy followed by peripheral stem cell transplantation for Non-Hodgkin lymphoma, …
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients [Phase 3]
Phase 3 trial evaluating mobilization of stem cells with plerixafor (AMD3100) in patients with Non-Hodgkin lymphoma has completed and posted…
-
CLINICAL_TRIALS trial_result · 2010-09-28Clinical Trial Update: Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
This clinical trial update indicates that a study evaluating hematopoietic recovery after chemotherapy in Non-Hodgkin's Lymphoma has been te…
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: High Dose CHOP in Lymphoma [Phase 2]
A Phase 2 trial evaluating high-dose CHOP chemotherapy in patients with Non-Hodgkin's Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma [Phase 1, Phase 2]
Phase 1/2 dose-finding trial of AMG 531 for chemotherapy-induced thrombocytopenia in adults with lymphoma; the study completed and results w…
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial comparing rituximab plus sargramostim versus rituximab alone in relapsed follicular B-cell lymphoma (a form of non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating a biological therapy after chemotherapy in patients with relapsed or refractory non-Hodgkin lymphoma has…
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin
This completed prospective observational study evaluated quality of life and costs in real-world patients treated with 90Y-Zevalin (ibritumo…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone [Phase 2]
Phase 2 trial of plerixafor (AMD3100) in multiple myeloma or non-Hodgkin lymphoma patients predicted to be unable to mobilize with G-CSF alo…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating the use of PET/CT imaging to assess treatment response in Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 study update evaluating the reproducibility of the BodyFIX immobilization device in Hodgkin lymphoma and non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating high-dose busulfan and high-dose cyclophosphamide conditioning followed by donor bone marrow transplantation in p…